MENU
ACLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arcellx (ACLX) Ownership - Who owns Arcellx?

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases... Show more

Profile

Industry
N/A
Address
800 Bridge Parkway
Phone
+1 240 327-0603
Employees
209
Web
https://www.arcellx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.73B
P/E Ratio
N/A
Total Cash
450.33M
Projected Growth
N/A
Total Debt
51.92M
Revenue
22.29M
Risk (Beta)
1.08
Dividend Yield
N/A
Total Cash/Share
7.70
Total Debt/Equity
N/A
Revenue/Share
0.40 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
800 Bridge Parkway
Phone
+1 240 327-0603
Employees
209
Web
https://www.arcellx.com